{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:25:18Z","timestamp":1760228718972,"version":"build-2065373602"},"reference-count":22,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>In response to our narrative review, which suggested the use of the glutamatergic n-methyl-D-aspartate (NMDA) receptor antagonist ketamine as a potential treatment for anorexia nervosa (AN) [...]<\/jats:p>","DOI":"10.3390\/nu14102119","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:18:11Z","timestamp":1653005891000},"page":"2119","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Reply to Skokou, M. Comment on \u201cKeeler et al. Ketamine as a Treatment for Anorexia Nervosa: A Narrative Review. Nutrients 2021, 13, 4158\u201d"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3905-9857","authenticated-orcid":false,"given":"Johanna Louise","family":"Keeler","sequence":"first","affiliation":[{"name":"Section of Eating Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London SE5 8AF, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Treasure","sequence":"additional","affiliation":[{"name":"Section of Eating Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London SE5 8AF, UK"},{"name":"South London and Maudsley NHS Foundation Trust, Bethlem Royal Hospital, Monks Orchard Road, Beckenham BR3 3BX, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8558-3396","authenticated-orcid":false,"given":"Mario F.","family":"Juruena","sequence":"additional","affiliation":[{"name":"South London and Maudsley NHS Foundation Trust, Bethlem Royal Hospital, Monks Orchard Road, Beckenham BR3 3BX, UK"},{"name":"Centre for Affective Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London SE5 8AF, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Kan","sequence":"additional","affiliation":[{"name":"Eating Disorder Service, Central and North West London NHS Foundation Trust, 1 Nightingale Place, Kensington & Chelsea, London SW10 9NG, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1209-6073","authenticated-orcid":false,"given":"Hubertus","family":"Himmerich","sequence":"additional","affiliation":[{"name":"Section of Eating Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London SE5 8AF, UK"},{"name":"South London and Maudsley NHS Foundation Trust, Bethlem Royal Hospital, Monks Orchard Road, Beckenham BR3 3BX, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Keeler, J.L., Treasure, J., Juruena, M.F., Kan, C., and Himmerich, H. (2021). Ketamine as a Treatment for Anorexia Nervosa: A Narrative Review. Nutrients, 13.","DOI":"10.3390\/nu13114158"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Skokou, M. (2022). Comment on Keeler et al. Ketamine as a Treatment for Anorexia Nervosa: A Narrative Review. Nutrients 2021, 13, 4158. Nutrients, 14.","DOI":"10.3390\/nu14102118"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-4328(02)00272-3","article-title":"Glutamate receptor function in learning and memory","volume":"140","author":"Riedel","year":"2003","journal-title":"Behav. Brain Res."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Stevens, L., and Rodin, I. (2011). Introduction to Drug Treatments. Psychiatry, Churchill Livingstone. [2nd ed.].","DOI":"10.1016\/B978-0-7020-3396-4.00014-7"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/0269881118754680","article-title":"Excitotoxicity in the pathogenesis of neurological and psychiatric disorders: Therapeutic implications","volume":"32","author":"Olloquequi","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Sasaki, T., Matsui, S., and Kitamura, T. (2016). Control of appetite and food preference by NMDA receptor and its co-agonist d-serine. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17071081"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1007\/s00213-014-3461-1","article-title":"Addicted to palatable foods: Comparing the neurobiology of Bulimia Nervosa to that of drug addiction","volume":"231","author":"Hadad","year":"2014","journal-title":"Psychopharmacology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1021\/acschemneuro.8b00601","article-title":"Shared Behavioral and Neurocircuitry Disruptions in Drug Addiction, Obesity, and Binge Eating Disorder: Focus on Group I mGluRs in the Mesolimbic Dopamine Pathway","volume":"10","author":"Yohn","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.pbb.2011.04.015","article-title":"Glutamatergic medications for the treatment of drug and behavioral addictions","volume":"100","author":"Olive","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1568026053386962","article-title":"Mechanisms of action of antiepileptic drugs","volume":"5","author":"Czapinski","year":"2005","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/01.pra.0000281484.89075.a8","article-title":"The application of exposure therapy and D-cycloserine to the treatment of anorexia nervosa: A preliminary trial","volume":"13","author":"Steinglass","year":"2007","journal-title":"J. Psychiatr. Pract."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.4088\/JCP.14m09299","article-title":"D-Cycloserine facilitation of exposure therapy improves weight regain in patients with anorexia nervosa: A pilot randomized controlled trial","volume":"76","author":"Levinson","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40479-017-0072-6","article-title":"A pilot open series of lamotrigine in DBT-treated eating disorders characterized by significant affective dysregulation and poor impulse control","volume":"4","author":"Trunko","year":"2017","journal-title":"Bord. Personal. Disord. Emot. Dysregulation"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/eat.22234","article-title":"Lamotrigine use in patients with binge eating and purging, significant affect dysregulation, and poor impulse control","volume":"47","author":"Trunko","year":"2014","journal-title":"Int. J. Eat. Disord."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Reilly, E.E., Berner, L.A., Trunko, M.E., Schwartz, T., Anderson, L.K., Krueger, A., Yu, X., Chen, J.Y., Cusack, A., and Nakamura, T. (2022). Evaluating the use of lamotrigine to reduce mood lability and impulsive behaviors in adults with chronic and severe eating disorders. Eat. Weight. Disord. Stud. Anorex. Bulim. Obes., 1\u201311.","DOI":"10.1007\/s40519-021-01320-3"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"107667","DOI":"10.1016\/j.pharmthera.2020.107667","article-title":"Pharmacological treatment of eating disorders, comorbid mental health problems, malnutrition and physical health consequences","volume":"217","author":"Himmerich","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"21395","DOI":"10.4088\/JCP.v64n1208","article-title":"Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 2: Improvement in psychiatric measures","volume":"64","author":"Hedges","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.4088\/JCP.v64n1109","article-title":"Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: Improvement in binge and purge measures","volume":"64","author":"Hoopes","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/eat.20202","article-title":"Topiramate treatment in bulimia nervosa patients: A randomized, double-blind, placebo-controlled trial","volume":"38","author":"Nickel","year":"2005","journal-title":"Int. J. Eat. Disord."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.biopsych.2006.08.008","article-title":"Topiramate for the treatment of binge eating disorder associated with obesity: A placebo-controlled study","volume":"61","author":"McElroy","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.4088\/JCP.v68n0901","article-title":"Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorder","volume":"68","author":"Claudino","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1176\/appi.ajp.160.2.255","article-title":"Topiramate in the treatment of binge eating disorder associated with obesity: A randomized, placebo-controlled trial","volume":"160","author":"McElroy","year":"2003","journal-title":"Am. J. Psychiatry"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/14\/10\/2119\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:14:38Z","timestamp":1760138078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/14\/10\/2119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,19]]},"references-count":22,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["nu14102119"],"URL":"https:\/\/doi.org\/10.3390\/nu14102119","relation":{},"ISSN":["2072-6643"],"issn-type":[{"type":"electronic","value":"2072-6643"}],"subject":[],"published":{"date-parts":[[2022,5,19]]}}}